Wilms Tumor Protein Market
According to Intent Market Research, the Wilms Tumor Protein Market is expected to grow from USD 1.1 Billion in 2024-e at a CAGR of 11.9% to touch USD 2.2 Billion by 2030. The Wilms Tumor Protein Market is dominated by key players such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Merck & Co. Inc., and Agilent Technologies Inc.